694 related articles for article (PubMed ID: 19033248)
1. Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation.
Moser C; Pohl G; Haslinger I; Knapp S; Rowczenio D; Russel T; Lachmann HJ; Lang U; Kovarik J
Nephrol Dial Transplant; 2009 Feb; 24(2):676-8. PubMed ID: 19033248
[TBL] [Abstract][Full Text] [Related]
2. Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure.
Stankovic Stojanovic K; Delmas Y; Torres PU; Peltier J; Pelle G; Jéru I; Colombat M; Grateau G
Nephrol Dial Transplant; 2012 May; 27(5):1898-901. PubMed ID: 21931121
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of anakinra treatment in a patient with colchicine-resistant familial Mediterranean fever.
Alpay N; Sumnu A; Calışkan Y; Yazıcı H; Türkmen A; Gül A
Rheumatol Int; 2012 Oct; 32(10):3277-9. PubMed ID: 20386914
[TBL] [Abstract][Full Text] [Related]
4. [Familial Mediterranean Fever (FMF): from diagnosis to treatment].
Medlej-Hashim M; Loiselet J; Lefranc G; Mégarbané A
Sante; 2004; 14(4):261-6. PubMed ID: 15745878
[TBL] [Abstract][Full Text] [Related]
5. Anakinra suppresses familial Mediterranean fever crises in a colchicine-resistant patient.
Mitroulis I; Papadopoulos VP; Konstantinidis T; Ritis K
Neth J Med; 2008 Dec; 66(11):489-91. PubMed ID: 19075317
[TBL] [Abstract][Full Text] [Related]
6. Familial mediterranean fever: a fascinating model of inherited autoinflammatory disorder.
Portincasa P; Scaccianoce G; Palasciano G
Eur J Clin Invest; 2013 Dec; 43(12):1314-27. PubMed ID: 24117178
[TBL] [Abstract][Full Text] [Related]
7. The effect of dialytic modalities on clinical outcomes in ESRD patients with familial Mediterranean fever.
Sahin S; Sahin GM; Ergin H; Kantarci G
Ren Fail; 2007; 29(3):315-9. PubMed ID: 17497446
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever.
Calligaris L; Marchetti F; Tommasini A; Ventura A
Eur J Pediatr; 2008 Jun; 167(6):695-6. PubMed ID: 17588171
[TBL] [Abstract][Full Text] [Related]
9. Familial Mediterranean fever: clinical, molecular and management advancements.
Lidar M; Livneh A
Neth J Med; 2007 Oct; 65(9):318-24. PubMed ID: 17954950
[TBL] [Abstract][Full Text] [Related]
10. Clinical features of familial Mediterranean fever: an Italian overview.
Manna R; Cerquaglia C; Curigliano V; Fonnesu C; Giovinale M; Verrecchia E; Montalto M; De Socio G; Soriano A; La Regina M; Gasbarrini G
Eur Rev Med Pharmacol Sci; 2009 Mar; 13 Suppl 1():51-3. PubMed ID: 19530512
[TBL] [Abstract][Full Text] [Related]
11. Secondary amyloidosis due to FMF.
Yonem O; Bayraktar Y
Hepatogastroenterology; 2007 Jun; 54(76):1061-5. PubMed ID: 17629039
[TBL] [Abstract][Full Text] [Related]
12. AA type renal amyloidosis secondary to FMF: a long-term follow-up in two patients.
Aybal Kutlugün A; Yildirim T; Altindal M; Arici M; Yasavul U; Turgan C
Ren Fail; 2010; 32(10):1230-2. PubMed ID: 20954987
[TBL] [Abstract][Full Text] [Related]
13. Anti-IL-1 treatment in familial Mediterranean fever and related amyloidosis.
Özçakar ZB; Özdel S; Yılmaz S; Kurt-Şükür ED; Ekim M; Yalçınkaya F
Clin Rheumatol; 2016 Feb; 35(2):441-6. PubMed ID: 25213327
[TBL] [Abstract][Full Text] [Related]
14. Anakinra in two adolescent female patients suffering from colchicine-resistant familial Mediterranean fever: effective but risky.
Gattringer R; Lagler H; Gattringer KB; Knapp S; Burgmann H; Winkler S; Graninger W; Thalhammer F
Eur J Clin Invest; 2007 Nov; 37(11):912-4. PubMed ID: 17973784
[No Abstract] [Full Text] [Related]
15. Diffuse pulmonary amyloidosis that mimics interstitial lung disease in a patient with familial Mediterranean fever.
Erdem H; Simşek I; Pay S; Dinc A; Deniz O; Ozcan A
J Clin Rheumatol; 2006 Feb; 12(1):34-6. PubMed ID: 16484879
[TBL] [Abstract][Full Text] [Related]
16. [Nephrotic syndrome in familial Mediterranean fever--effect of colchicine therapy].
Højberg AS; Mertz H
Ugeskr Laeger; 1995 Jul; 157(28):4035-7. PubMed ID: 7645081
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of renal transplantation in patients with familial Mediterranean fever amyloidosis: a single-center experience.
Keven K; Sengul S; Kutlay S; Ekmekci Y; Anadol E; Nergizoglu G; Ates K; Erturk S; Erbay B
Transplant Proc; 2004 Nov; 36(9):2632-4. PubMed ID: 15621109
[TBL] [Abstract][Full Text] [Related]
18. Familial mediterranean fever - a review and update.
Orbach H; Ben-Chetrit E
Minerva Med; 2001 Dec; 92(6):421-30. PubMed ID: 11740430
[TBL] [Abstract][Full Text] [Related]
19. [Fever of unknown origin and colchicine-sensitive amyloidosis: familial Mediterranean fever?].
Schneider W; Wehmeier A
Dtsch Med Wochenschr; 1989 Jun; 114(24):951-4. PubMed ID: 2731480
[TBL] [Abstract][Full Text] [Related]
20. Novel therapeutics for the treatment of familial Mediterranean fever: from colchicine to biologics.
Grattagliano I; Bonfrate L; Ruggiero V; Scaccianoce G; Palasciano G; Portincasa P
Clin Pharmacol Ther; 2014 Jan; 95(1):89-97. PubMed ID: 23867542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
